CVE:MNX

Manitex Capital Stock Forecast, Price & News

C$0.80
-0.01 (-1.23 %)
(As of 08/12/2021)
Add
Compare
Today's Range
C$0.80
C$0.80
50-Day Range
C$0.80
C$0.99
52-Week Range
C$0.67
C$1.30
Volume20,000 shs
Average Volume4,873 shs
Market CapitalizationC$10.05 million
P/E Ratio11.43
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive MNX News and Ratings via Email

Sign-up to receive the latest news and ratings for Manitex Capital and its competitors with MarketBeat's FREE daily newsletter.


About Manitex Capital

Manitex Capital Inc. focuses on acquiring interests in life sciences, cleantech, and sustainable products/technologies companies. The company also holds a portfolio of marketable securities. The company is headquartered in Kirkland, Canada.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.31 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Manitex Capital (CVE:MNX) Frequently Asked Questions

What stocks does MarketBeat like better than Manitex Capital?

Wall Street analysts have given Manitex Capital a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Manitex Capital wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Manitex Capital's key executives?

Manitex Capital's management team includes the following people:
  • Mr. Steven Saviuk, Chairman, Pres & CEO (Age 62, Pay $250k)
  • Ms. Helen Saviuk, CFO & Director
  • Mr. Ronald S. Perry CA, CPA, Sec. (Age 65)
  • Mr. Kristof Biniecki, VP of Scientific Affairs - Valeo Pharma Inc
  • Mr. Marc Léger, Exec. VP of Commercial Operations - Valeo Pharma Inc
  • Nathalie Therrien, Vice-Pres of QA & Regulatory Affairs - Valeo Pharma Inc.
  • Mr. Luc Mainville M.B.A., M.B.A, Sr. VP & CFO of Valeo Pharma Inc (Age 57)

Who are some of Manitex Capital's key competitors?

What is Manitex Capital's stock symbol?

Manitex Capital trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MNX."

How do I buy shares of Manitex Capital?

Shares of MNX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Manitex Capital's stock price today?

One share of MNX stock can currently be purchased for approximately C$0.80.

How much money does Manitex Capital make?

Manitex Capital has a market capitalization of C$10.05 million and generates C$-1,043,068.00 in revenue each year.

What is Manitex Capital's official website?

The official website for Manitex Capital is www.manitexcapital.com.

How can I contact Manitex Capital?

The company can be reached via phone at 514-693-8844.


This page was last updated on 9/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.